Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
Detection of Microsatellite Instability (MSI) in Circulating Tumor DNA of Patients With Stage IV Colorectal Carcinoma
Sponsor: National Cancer Institute (NCI)
Terminated
Insufficient accrual
Other terminated trials from National Cancer Institute (NCI)
A observational or N/A phase clinical study on Colorectal Cancer Stage IV and Microsatellite Instability, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 12 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
▶ Show 7 earlier versions
-
May 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
Jan 2019 — Apr 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Jan 2019 [monthly]
Not Yet Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .